IDPH: Office of Health Protection

The Harm Reduction Community Linkages Project is to support capacity building at harm reduction organizations statewide to expand their client base and develop more comprehensive linkages to prevention, treatment and harm reduction services for individuals with opioid use disorder (OUD), including prescription opioids as well as illicit drugs such as heroin. This project is funded through the Centers for Disease Control and Prevention (CDC) Overdose Data to Action Cooperative Agreement. Organizations selected for this funding will need to demonstrate success in engaging individuals with opioid use disorder (OUD), including prescription opioids as well as illicit drugs such as heroin; have experience in linking individuals to prevention, treatment and harm reduction services through community referral networks; and show capacity to cover large geographic regions in Illinois that demonstrate a high burden of opioid overdose. These funds will be used to strengthen partnerships between harm reduction community stakeholders and treatment providers in order to improve local coordination, connect more individuals to the appropriate support services and treatment for OUD, and provide case management as needed among persons who inject opioids.

N/A

Department of Public Health Power and Duties Law, 20ILCS 2310/2310-25

Department of Public Health Power and Duties Law, 20ILCS 2310/2310-25

Increase linkages to harm reduction services in Illinois

Yes

9/1/21-8/31/22

Government Organizations; Nonprofit Organizations;

Must have received a Harm Reduction Grant from IDPH in 20222.

Harm reduction clients

Non-competitive

Public Safety

N/A

N/A

Standard application settings – no custom documentation . Applications must be submitted via the Illinois Department of Public Health's Electronic Grants Administration and Management System (EGrAMS), accessible at idphgrants.com.

Submission of completed and approved application

Submission of completed and approved application

30 days after posting

30 days

N/A

Option for One renewals

N/A

Unallowable Costs - Research; Purchase of naloxone; Purchase of syringes; Drug disposal programs (drop-boxes, bags or other devices, and/or take-back events) are not permissible under this funding opportunity; Clinical care (except as allowed by law); Publicity and propaganda (lobbying); Funds cannot be used for the preparation, distribution, or use of any material (publicity/propaganda) or to pay the salary or expenses of grants, contract recipients, or agents that aim to support or defeat the enactment of legislation, regulation, administrative action, or executive order proposed or pending before a legislative body, beyond normal, recognized executive relationships.

Quarterly programmatic reports, monthly fiscal reports

N/A

Record retention will be in compliance with GATA and UG

063-48220-1900-0000

$1,706,513

$81,598 - $576,258

N/A

N/A

N/A

Springfield, IL

N/A

N/A

N/A

9/1/2021

FY 2019 : $459,000
FY 2020 : $270,026
FY 2021 : $270,026
FY 2022 : $3,600,000
FY 2023 : $1,706,513